Basic Information
Basic information for MKLN1-AS-202-17aa
Peptide Name MKLN1-AS-202-17aa
Genome Position chr7:131323636-131323686[-]
Species Human
Peptide Sequence MGYCLVVSGKVDPSNLE
Peptide Length 17
Unique No (MKLN1-AS-201-17aa,MKLN1-AS-203-17aa,MKLN1-AS-205-17aa,MKLN1-AS-206-17aa,MKLN1-AS-207-17aa,MKLN1-AS-208-17aa,MKLN1-AS-209-17aa,MKLN1-AS-210-17aa,MKLN1-AS-211-17aa-2,MKLN1-AS-212-17aa-2,MKLN1-AS-213-17aa,MKLN1-AS-214-17aa,MKLN1-AS-215-17aa,MKLN1-AS-216-17aa)
Grand Average of Hydropathicity 0.2882
Relative Molecular Mass 2099.34
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236753;MKLN1-AS
Transcript ID/Name ENST00000429067;MKLN1-AS-202
Transcript Length 2043
Coding Ability 0.3069
DNA Sequence Corresponding to Peptide ATGGGGTACTGTCTTGTAGTATCTGGGAAAGTAGACCCATCTAACCTGGAA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :